Breaking News
USFDA APPROVES POTASSIUM CHLORIDE ER CAPSULES FROM GRANULES INDIA
ONWARD THERAPEUTICS AND BIOMUNEX PHARMACEUTICALS SIGN NEW AGREEMENT
FRANCE BEGINS DISTRIBUTING COVID VACCINE AMID UK VARIANT WARNING
UK HEALTHCARE KENTUCKY’S FIRST EXCELLENT SYSTEM FOR HIDDEN SCAR BREAST CANCER SURGERY
Skip to content
  • Home
  • Healthcare
  • Medicine
  • Pharamaceuticals
  • Research
Medgazette 24

Medgazette 24

Healthcare Latest news, Medical Technology Updated News

  • Home
  • Healthcare
  • Medicine
  • Pharamaceuticals
  • Research
  • Home
  • Pharamaceuticals

Category: Pharamaceuticals

USFDA APPROVES POTASSIUM CHLORIDE ER CAPSULES FROM GRANULES INDIA

February 26, 2021 medgazettePharamaceuticals

HIGHLIGHTS USFDA has approved potassium chloride ER capsules from Granules India. Potassium Chloride is useful for the treatment of patients suffering from hypokalemia. Potassium Chloride can be helpful in the treatment of in digitalis intoxications. Patients with hypokalemic familial periodic…

UK GOVERNMENT EXTENDS WOCKHARDT’S CONTRACT CREATING NEW JOBS

February 19, 2021 medgazettePharamaceuticals

HIGHLIGHTS UK Government has extended its contract with Wockhardt. Extension of contract creates 40 new jobs. Under the extanded contract, a Wrexham factory is aiding the production of COVID-19 vaccines. The UK Government wants to ensure huge supply and long…

ARTIOS PHARMA ANNOUNCES FIRST CLINICAL STUDY REGARDING ADVANCED NEXT-GEN DDR

February 18, 2021 medgazettePharamaceuticals, Research

HIGHLIGHTS Artios Pharma is now turning into a clinical-stage precision medicine company. Artios Pharma is advancing the next generation DDR treatment. Known to be a leading DNA Damage Response (DDR) company, Artios Pharma Limited has been developing a broad pipeline…

UK TALKING TO PHARMA COMPANIES ABOUT EARLY ACCESS TO MODIFIED VACCINES

February 11, 2021 medgazettePharamaceuticals

HIGHLIGHTS Massive increase in coronavirus infections has caused complete lockdown in the UK. UK witnessed rapid and massive increase in the number of coronavirus infections in past few months. UK government is talking to pharma companies regarding early access to…

JAZZ PHARMACEUTICALS TO TAKE OVER GW PHARMACEUTICALS

February 10, 2021 medgazettePharamaceuticals

HIGHLIGHTS Jazz Pharmaceuticals is growing its portfolio of neuroscience therapies with the new deal. GW Pharmaceuticals specializes in a cannabis-derived treatment for epilepsy. Jazz Pharmaceuticals is taking over the United Kingdom (UK)–based pharmaceutical firm called GW Pharmaceuticals that specializes in…

MARK CUBAN AIMS TO BRING AFFORDABLE DRUGS TO USA WITH NEW COMPANY

February 9, 2021 medgazettePharamaceuticals

HIGHLIGHTS Mark Cuban has launched a new pharmaceutical company called Cost Plus Drug Company. The new company aims to bring affordable drugs in the American market. The cost of medicines and healthcare drugs is rapidly increasing in the United States…

Pfizer TO COME UP WITH A POWDERED VERSION OF ITS COVID-19 VACCINE

November 11, 2020 medgazettePharamaceuticals

Highlights • Mikael Dolsten, Pfizer’s chief scientific officer said this version of the vaccine is already being planned and likely to be available next year • Pfizer Chairman and CEO said “We are a significant step closer to providing people…

Pfizer TO DISTRIBUTE COVID-19 VACCINE INDEPENDENTLY IN THE U.S.

November 5, 2020 medgazettePharamaceuticals

Highlights • Tanya Alcorn,Pfizer said that the company is coming up with its own distribution system to deliver their COVID-19 vaccine directly to healthcare providers instead of going ahead with the government’s chosen distribution partner, McKesson • This statement by…

Acquired Hemophilia: A Life Threatening Bleeding Disorder

March 16, 2020 Shreyas TannaHealthcare, News, Pharamaceuticals

Highlights What is Acquired Hemophilia Disorder Symptoms of Acquired Hemophilia Disorder Causes of Acquired Hemophilia Disorder Diagnosis of Acquired Hemophilia Disorder Various therapies for treating Acquired Hemophilia Disorder Antibodies, Factor VIII, hemostasis, inhibitors, etc. Summary Acquired hemophilia is rare and…

NICE Approves Ajovy

March 16, 2020March 16, 2020 Shreyas TannaPharamaceuticals

HIGHLIGHTS With thee approval from NICE, Ajovy can be used for treating prophylaxis of migraine in adults with chronic migraine unresponsive to at least three prior preventive treatments. The decision from NICE can definitely help many people as Migraine therapies…

Posts navigation

1 2 … 34 Next

Recent News

MAXWELLIA TO LAUNCH THREE PHARMACY PRODUCTS SOON

February 15, 2021

AUSTRALIAN STARTUP LAUNCHES NEW LASER TECH TO PREVENT HEART ATTACKS

February 12, 2021

UK TALKING TO PHARMA COMPANIES ABOUT EARLY ACCESS TO MODIFIED VACCINES

February 11, 2021

JAZZ PHARMACEUTICALS TO TAKE OVER GW PHARMACEUTICALS

February 10, 2021

MARK CUBAN AIMS TO BRING AFFORDABLE DRUGS TO USA WITH NEW COMPANY

February 9, 2021

UK RESTRICTS COVID MEDICINE EXPORTS

February 8, 2021

GERMANY FIRST EU NATION TO USE COVID-19 MEDICINES USED FOR TREATMENT OF DONALD TRUMP

February 5, 2021

Allscripts Partners With US Orthopedic Alliance

February 4, 2021

KOMODO HEALTH PARTNERS WITH BLUE HEALTH INTELLIGENCE TO UPGRADE HEALTHCARE MAP

February 3, 2021

PAPA’S HEALTH SERVICES AVAILABLE ON HEALTHIFY

February 2, 2021

Categories

  • Healthcare
    • Healthcare IT
  • Medicine
  • News
  • Pharamaceuticals
  • Research
Medicine
February 17, 2021

GROW PHARMA AND TILRAY SEAL THE DEAL REGARDING MEDICAL MARIJUANA EXPORT

HIGHLIGHTS Grow Pharma and Tilray have signed a deal regarding medical marijuana…

Medicine
February 16, 2021

UK HELPS INDIGENOUS COMMUNITIES TO PROTECT ANCIENT TRADITIONAL MEDICINE

HIGHLIGHTS A project in UK is helping indigenous communities in Guatemala and…

  • About Us
  • Authors
  • Contact Us
Copyright © All rights reserved.
Powered by WordPress | Magazine Point by Axle Themes